Kronos Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Kronos Bio and buy or sell other stocks, ETFs, and their options commission-free!

About KRON

Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. 

CEO
Deborah A. Knobelman, PhD
CEODeborah A. Knobelman, PhD
Employees
—
Employees—
Headquarters
San Mateo, California
HeadquartersSan Mateo, California
Founded
2017
Founded2017
Employees
—
Employees—

KRON Key Statistics

Market cap
53.65M
Market cap53.65M
Price-Earnings ratio
-0.82
Price-Earnings ratio-0.82
Dividend yield
—
Dividend yield—
Average volume
—
Average volume—
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.46
52 Week high$1.46
52 Week low
$0.65
52 Week low$0.65

Stock Snapshot

As of today, Kronos Bio(KRON) shares are valued at $0.88. The company's market cap stands at 53.65M, with a P/E ratio of -0.82.

On 2026-10-26, Kronos Bio(KRON) stock opened at —, reached a high of —, and a low of —.

Kronos Bio(KRON) shares are trading with a volume of 0.

During the past year, Kronos Bio(KRON) stock moved between $0.65 at its lowest and $1.46 at its peak.

During the past year, Kronos Bio(KRON) stock moved between $0.65 at its lowest and $1.46 at its peak.

People also own

Based on the portfolios of people who own KRON. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.